A1060A

The New York State Senate passed legislation (A1060A) amending the Education Law and Public Health Law to expand access to birth control and hormone-related medications, with a vote of 48-15 on March 28. The bill allows pharmacists to dispense certain medications without requiring prior consultation with a patient's primary care physician, though it includes safeguards such as mandatory self-screening questionnaires and referral to primary care providers within 72 hours. The measure comes in response to the U.S. Supreme Court's 2022 decision overturning Roe v. Wade. Sen. Stavisky, voting in favor, emphasized the bill's protective measures and the importance of ensuring women's access to contraception. Sen. Canzoneri-Fitzpatrick voted against the measure, expressing concern that minors could obtain hormone replacement drugs without mandatory pharmacist consultation with their primary care physicians, potentially missing dangerous medical contraindications such as blood-clotting disorders. Fifteen senators voted in opposition, primarily from the Republican conference.